期刊文献+

EGb防治PD的实验研究 被引量:5

The experimental study of EGb's prevention from the PD
下载PDF
导出
摘要 目的 观察银杏叶提取物 (Ginkgobilobaleaves ,EGb)在 1 甲基 4 苯基 1,2 ,3 ,6 四氢吡啶 ( 1 methyl 4 phenyl 1,2 ,3 ,6 tetrahyropyridine ,MPTP )诱导的帕金森氏病 (PD)模型中对旋转症状及纹状体中多巴胺 (dopamine,DA )含量的影响。方法 腹腔注射EGb连续 2 0d ,采用大脑立体定位仪向大鼠黑质内注射MPTP诱导旋转 ,观察大鼠旋转情况 ,测定大鼠相关脑区中DA含量的变化。结果 EGb相对增加了纹状体中DA的含量 ,改善了PD的旋转症状。 Objective The aim was to investigate the effect of the extract of Ginkgo biloba leaves (EGb) on the rotation and DA content of the PD model induced by 1 methyl 4 phenyl 1,2,3,6 tetrahyropyridine (MPTP). Methods The EGb were administered by intraperiton for continuous 20 days. On the day 20, the MPTP were microinjected 40μg/kg into the substantian nigra of rat brain, then observed the symptom of rotation and determine the content of dopamine (DA) in the striatum. Results EGb inhibited the reduction of DA at doses of 50mg/kg and 100mg/kg (P<0.05, P<0.01 respectively), and improve the symptom of rotation. Conclusions Present study indicated that EGb have preventive effect on the PD model.
出处 《遵义医学院学报》 2001年第3期206-208,共3页 Journal of Zunyi Medical University
  • 相关文献

参考文献10

  • 1Sirinathsinghji DJS Behavioral effects in the rat a fter acute unilateral intranigral infusions of N-methyl-4-phenyl-1, 2,3, 6-tetrahydropyridine[J]. Brain Research, 1985; 339:366-370.
  • 2Whittington PE, Audsley AR. Neurochemical changes in the substantiae nigrae and caudate N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine [ J ]. Brain Research, 1986,399:339- 345.
  • 3许建,金国章.脑内单胺类神经递质的荧光分光光度测定法.见:徐叔云卞如濂,陈修主编.药理实验方法学[M].北京:人民卫生出版社,1991,440-446.
  • 4Markey SP, Johannessen J, Chiueh, CC, et al.Intraneuroal generation of a Pyridinium metabolite may cause drug-induced Parkinsonism in primates [J].Science, 1984,225:1480-1482.
  • 5Javitch, J A and Snyder S H. Uptake of MPP+ by dopamine neurons explains selectivity of Parkinsonisminducing neurotoxin, MPTP [J ]. Eur. J. Pharmcol,1984,106: 455-456.
  • 6Kalaria R N and Harik S I, Blood-brain barriermonoamine oxidase: enzyme characterization in cerebral microvessels and other tissues from six mammalian species[J ]. including human. J. Neurochem, 1987,49: 856-864 .
  • 7Kalaria R N, Mitchell M J, Harik S I. Correlations Of 1methyl-4- phenyl-1, 2, [ J ], 6-tetrahydropyridine neurotoxicity with blood-brain barrier monoamine oxidase activity[J]. Proc. Nat. Acad. Sci .USA,1987,84:3521.
  • 8Heikkila R E, Hess A, Duvoisin R C. Dopaminergic neuritoxicity of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropridine in mice[J ]. Science, 1998,224: 1451-1453.
  • 9Johannessen J N,Chiueh C C, Burns R S,et al. Difference in the metabolism of MPTP in the rodent and primate.Parrel difference in sensitivity to its neurotoxicity effect[J]. Life Science, 1985,36: 219-224.
  • 10Charles R, FrancoisC, Yves C, et al. Prevention by Ginkgo biloba Extract (GBE761) of the Dopaminergic Neurotoxicity of MPTP [J]. J. Pharm. Pharmacol.1990, 42:785-789.

同被引文献63

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部